_id
690daf31ccc777a4e85d0ae9
Ticker
ANTCF
Name
Aion Therapeutic Inc
Exchange
PINK
Address
700 West Georgia Street, Vancouver, BC, Canada, V7Y 1K8
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.aiontherapeutic.com/
Description
Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada.
Last Close
0.0017
Volume
-
Current Price
0.0017
Change
0
Last Updated
2026-01-22T08:02:08.067Z
Image
data:image/webp;base64,UklGRnQGAABXRUJQVlA4IGgGAAAwGgCdASpAAEAAPp08lkmloyIhOf2IALATiWwArk8ABhSE7E1VAgXbJzAfOv0ReYB+qXSU8wH7L+qX6Hv2J9gD9hutf9Avy3/Zn/db0jcBF29YkeWH1ZH6OL+o/6j+t+iP+c8QffHqBO66ob6v37mov316DO/K899Cv0AfLHoi0M7ptgAfOJrkA1De2fYq1WKWmV3+/BQjEv9gMyBXNrJRWtqgxd9H9ny0IyeZQ0KKZDJ71xkdht9O4KR2g/dWpq8qDKNEoQZuF8J10gwDP7109rxSDP9dRx3g4AD+8JXidQpDbmn6kZco9ZTafqEBqeb2eSm305b3AuLxvS9DBb+f6+9J+OpkfuL2sZPyXFu/FJHfiSBuqGmmWFlhsA3tJ0KUp50c2Iy3/9olT/30o0Svrunz05n+oIeTer0UP8eqQjxPrHDTY17dfMLTIgY9d5d/jtASPV/A0e/H4jLhqlvj0XtXL6o4uxSvYrzr/6rnM6RoT2eA0X2lgYDZtFUsNrmA4m4YQuuZp0xp1P7W60TQtYel5r2giyHWuSXrIpGm/vKIag9EfJaNmHlXhAg+QjTVA9Iu1pL9LXGf9ZEBxWK7U7j62baHM5fFcvjFltE9GzbftVrddERRvaTbd5ixAe6IEFG3HhwVjhDxuPG+eNPyJtXZxX/30gtNA5uhVzfagP/itJNcB3hy0yZOoJ2Lk16aWs75/Jis2C5bjDHb3ZZS3urcAAQzz8RahwlKFok7ITvdDY0Iaq5qR9fRwoZFUm8u8UC3J70/hd9waLyn1+hH90k8r1jN9+eETkQGKnFZWAQ5qUl/LM1dRNomRruTeCjevclGjn0S6GJgmf6oERtbap+NjT+ux53G/cj6c6kaTzK21mhbI9onpn+o//qpUTsqehkiJzSiLAUsmHrQeG50ROekn7cz5kbODMHKZMvFEpJGrG+NtJx/IklAZmglkNowh1Nka0v86lixGOXjbLZEfJzQcftmaXWpmnGl2+IhYvH2QcL+qR8cYVyrumbzcCcbDTn/8FSQglyDokqdJOgJxrGjzJC4axmhkRrFsNJwmz0ZgXB7B4HcDnTQ+qZ6PPFqm5MT2ujGtL0bT0LxbeWbDovjJfNouGR8Ae7uB1chacPAuKjeUQ+UmYbO1aRrGuSF/bksGTQAecTE57Jp2QI68Cm8PMaL6nh3FZe4g5dXl2CV4g/XyccNu7OJU1YZv3bcRGGIeFqmlUsIi1i5vwlRjkPyY5lCKL+hBPtYazEX+F+T3n/78m99eX7RwS3HE4U4BsJLBOzeaxHei/tAqcPPBm5af8fLRHOVu8Fy5VN3wS+xPYm8xuug4XHbkwjFF4EV6RuE8x3EMyEKINxyz5EYRn0Z1qqTkq+/XvKlw+CbEkK1Xy3qrREQLb6xyEe2Zj+P9EzvNwwceKM04cDzvkJq4i5hgZ4mbKUon/q+bOJQqSpEomeI43V953rXkfUKN1Iqw+X1MfFuX2lXzHcpMQUla5DfO1hcskDpqtyCyXSC9P2kL9tvfY0ASgYX4KVPHA13RSOg0Brft7fL+YDmVmgvrl2pzom4418J1g0NlE/nfRTpAuNaE8geHeSaZO3p8vF97eItJZlrcZwXYmCnZa7iTgpfGAo7B0LrcolT39082Ao6rP+ndwN/7udcCwr0t85JqTbJ/M48BlcNp5i487X/Cwi/TDxC9JF8LuPDq8gHBdCI8MA/NmwgALMnuU9a7WK1Ceb1MFckLZNVjqLEIEY6fHYGkfEM4ospJm3RONVtJZdbWGV/SLofdg8M4R2aqdjAhMzJro+OrvzPLT3Vzexapz6rbbcgXtmlyf4rqs99QlmRFuQ8otXPR+XER723FnP029L+1OKSrgmC7ZQxsM7vH0BwqgAnDLMXmvi49/p3Cj8RNlDfzHkFyPB5RBQuhED8iWXnfSYJgJscUDb/zUOriV/QHGgE+R/pt0GM+ZkKoq/mR86MKStEsDKA2e5xXDBwnFnIUXbuZUbHz6wRcBPQ9gyZcDZXGA/p9Oz0pgfMFvUSHocW5xRl28vdQs4T49AZYiDzoBM72hB2/2XMipawSmhbXbbVuk3P9bf4VxAyjDmYMwISwfJEOV8DDZ1RzcnsFBhst70IdV8u64SEbAA1PmfMhC7CCF4R91o3r+uAEXQUg3Asth1ELF33s1MAiP9f5FZuWcwAAA==
Ipo Date
-
Market Cap
1067706
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-01-31
Revenue
544985
Cost Of Revenue
331097
Gross Profit
213888
Operating Expenses
453939
Operating Income
-240051
Interest Expense
161200
Pretax Income
-292464
Net Income
-292464
Eps
-0.0005882820678551576
Dividends Per Share
-
Shares Outstanding
497149269
Income Tax Expense
-
EBITDA
-93539
Operating Margin
-44.04726735598227
Total Other Income Expense Net
-52413
Cash
13820
Short Term Investments
-
Receivables
160751
Inventories
407532
Total Current Assets
1120296
Property Plant Equipment
85144
Total Assets
1206380
Payables
2851000
Short Term Debt
2809351
Long Term Debt
-
Total Liabilities
5879066
Equity
-4672686
Bs_currency_symbol
CAD
Depreciation
37725
Change In Working Capital
50662
Cash From Operations
-43712
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
237130
Net Change In Cash
-79875
Cf_currency_symbol
CAD
PE
-
PB
-0.18087107871147345
ROE
6.259012482328151
ROA
-24.243107478572256
FCF
-43712
Fcf Percent
-0.08020771213886621
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
1
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-01-31
Quarters > 0 > income Statement > revenue
544985
Quarters > 0 > income Statement > cost Of Revenue
331097
Quarters > 0 > income Statement > gross Profit
213888
Quarters > 0 > income Statement > operating Expenses
453939
Quarters > 0 > income Statement > operating Income
-240051
Quarters > 0 > income Statement > interest Expense
161200
Quarters > 0 > income Statement > pretax Income
-292464
Quarters > 0 > income Statement > net Income
-292464
Quarters > 0 > income Statement > eps
-0.0005882820678551576
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
497149269
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-93539
Quarters > 0 > income Statement > operating Margin
-44.04726735598227
Quarters > 0 > income Statement > total Other Income Expense Net
-52413
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
13820
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
160751
Quarters > 0 > balance Sheet > inventories
407532
Quarters > 0 > balance Sheet > total Current Assets
1120296
Quarters > 0 > balance Sheet > property Plant Equipment
85144
Quarters > 0 > balance Sheet > total Assets
1206380
Quarters > 0 > balance Sheet > payables
2851000
Quarters > 0 > balance Sheet > short Term Debt
2809351
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5879066
Quarters > 0 > balance Sheet > equity
-4672686
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-292464
Quarters > 0 > cash Flow > depreciation
37725
Quarters > 0 > cash Flow > change In Working Capital
50662
Quarters > 0 > cash Flow > cash From Operations
-43712
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
237130
Quarters > 0 > cash Flow > net Change In Cash
-79875
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.0005882820678551576
Quarters > 0 > ratios > PB
-0.18087107871147345
Quarters > 0 > ratios > ROE
6.259012482328151
Quarters > 0 > ratios > ROA
-24.243107478572256
Quarters > 0 > ratios > FCF
-43712
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.08020771213886621
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2024-10-31
Quarters > 1 > income Statement > revenue
347625
Quarters > 1 > income Statement > cost Of Revenue
201950
Quarters > 1 > income Statement > gross Profit
145675
Quarters > 1 > income Statement > operating Expenses
658643
Quarters > 1 > income Statement > operating Income
-512968
Quarters > 1 > income Statement > interest Expense
64462
Quarters > 1 > income Statement > pretax Income
-582813
Quarters > 1 > income Statement > net Income
-582813
Quarters > 1 > income Statement > eps
-0.0012041338662948959
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
484010139
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-489758
Quarters > 1 > income Statement > operating Margin
-147.5636102121539
Quarters > 1 > income Statement > total Other Income Expense Net
-69845
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
93695
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
167696
Quarters > 1 > balance Sheet > inventories
582978
Quarters > 1 > balance Sheet > total Current Assets
1425145
Quarters > 1 > balance Sheet > property Plant Equipment
117435
Quarters > 1 > balance Sheet > total Assets
1541640
Quarters > 1 > balance Sheet > payables
2690966
Quarters > 1 > balance Sheet > short Term Debt
2404541
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5648569
Quarters > 1 > balance Sheet > equity
-4106929
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-582813
Quarters > 1 > cash Flow > depreciation
28593
Quarters > 1 > cash Flow > change In Working Capital
342224
Quarters > 1 > cash Flow > cash From Operations
-148271
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
76964
Quarters > 1 > cash Flow > net Change In Cash
12739
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.0012041338662948959
Quarters > 1 > ratios > PB
-0.20034854176928793
Quarters > 1 > ratios > ROE
14.190968482776304
Quarters > 1 > ratios > ROA
-37.80474040632054
Quarters > 1 > ratios > FCF
-148271
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.4265257101761956
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2024-07-31
Quarters > 2 > income Statement > revenue
434860
Quarters > 2 > income Statement > cost Of Revenue
241444
Quarters > 2 > income Statement > gross Profit
193416
Quarters > 2 > income Statement > operating Expenses
193416
Quarters > 2 > income Statement > operating Income
-271634
Quarters > 2 > income Statement > interest Expense
53210
Quarters > 2 > income Statement > pretax Income
-370811
Quarters > 2 > income Statement > net Income
-370811
Quarters > 2 > income Statement > eps
-0.001019486847005534
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
363723182
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-288925
Quarters > 2 > income Statement > operating Margin
-62.4647012831716
Quarters > 2 > income Statement > total Other Income Expense Net
-370811
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
80956
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
39939
Quarters > 2 > balance Sheet > inventories
527205
Quarters > 2 > balance Sheet > total Current Assets
1074449
Quarters > 2 > balance Sheet > property Plant Equipment
142553
Quarters > 2 > balance Sheet > total Assets
1217000
Quarters > 2 > balance Sheet > payables
2767847
Quarters > 2 > balance Sheet > short Term Debt
2503232
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5271079
Quarters > 2 > balance Sheet > equity
-4054077
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-370811
Quarters > 2 > cash Flow > depreciation
28676
Quarters > 2 > cash Flow > change In Working Capital
-255295
Quarters > 2 > cash Flow > cash From Operations
-544928
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
569050
Quarters > 2 > cash Flow > net Change In Cash
12620
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.001019486847005534
Quarters > 2 > ratios > PB
-0.1525203910532533
Quarters > 2 > ratios > ROE
9.146619563466604
Quarters > 2 > ratios > ROA
-30.469268693508628
Quarters > 2 > ratios > FCF
-544928
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.2531113461803798
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2024-04-30
Quarters > 3 > income Statement > revenue
145436
Quarters > 3 > income Statement > cost Of Revenue
146040
Quarters > 3 > income Statement > gross Profit
-604
Quarters > 3 > income Statement > operating Expenses
-604
Quarters > 3 > income Statement > operating Income
-512019
Quarters > 3 > income Statement > interest Expense
52277
Quarters > 3 > income Statement > pretax Income
-5399303
Quarters > 3 > income Statement > net Income
-5399303
Quarters > 3 > income Statement > eps
-0.013119457150584806
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
411549269
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5319893
Quarters > 3 > income Statement > operating Margin
-352.05794988861084
Quarters > 3 > income Statement > total Other Income Expense Net
-4946844
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
68336
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
50371
Quarters > 3 > balance Sheet > inventories
402901
Quarters > 3 > balance Sheet > total Current Assets
531858
Quarters > 3 > balance Sheet > property Plant Equipment
171003
Quarters > 3 > balance Sheet > total Assets
702861
Quarters > 3 > balance Sheet > payables
2493171
Quarters > 3 > balance Sheet > short Term Debt
2081539
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4574710
Quarters > 3 > balance Sheet > equity
-3871849
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-5399303
Quarters > 3 > cash Flow > depreciation
27133
Quarters > 3 > cash Flow > change In Working Capital
-376053
Quarters > 3 > cash Flow > cash From Operations
-808882
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
528951
Quarters > 3 > cash Flow > net Change In Cash
-280947
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.013119457150584806
Quarters > 3 > ratios > PB
-0.18069758332517613
Quarters > 3 > ratios > ROE
139.45024715581624
Quarters > 3 > ratios > ROA
-768.1893005871716
Quarters > 3 > ratios > FCF
-808882
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.561772876041696
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-04-30
Annuals > 0 > income Statement > revenue
367479
Annuals > 0 > income Statement > cost Of Revenue
204362
Annuals > 0 > income Statement > gross Profit
163117
Annuals > 0 > income Statement > operating Expenses
163117
Annuals > 0 > income Statement > operating Income
-1190949
Annuals > 0 > income Statement > interest Expense
171392
Annuals > 0 > income Statement > pretax Income
-6287196
Annuals > 0 > income Statement > net Income
-6287196
Annuals > 0 > income Statement > eps
-0.023718835107931917
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
265071871
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-6073698
Annuals > 0 > income Statement > operating Margin
-324.0862743177161
Annuals > 0 > income Statement > total Other Income Expense Net
-6287196
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
68336
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
50371
Annuals > 0 > balance Sheet > inventories
402901
Annuals > 0 > balance Sheet > total Current Assets
531858
Annuals > 0 > balance Sheet > property Plant Equipment
171003
Annuals > 0 > balance Sheet > total Assets
702861
Annuals > 0 > balance Sheet > payables
2493171
Annuals > 0 > balance Sheet > short Term Debt
2081539
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4574710
Annuals > 0 > balance Sheet > equity
-3871849
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-6287196
Annuals > 0 > cash Flow > depreciation
42106
Annuals > 0 > cash Flow > change In Working Capital
349259
Annuals > 0 > cash Flow > cash From Operations
-845045
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-289422
Annuals > 0 > cash Flow > cash From Financing
1120159
Annuals > 0 > cash Flow > net Change In Cash
68000
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.023718835107931917
Annuals > 0 > ratios > PB
-0.11638423417338847
Annuals > 0 > ratios > ROE
162.38226232479624
Annuals > 0 > ratios > ROA
-894.5148471746191
Annuals > 0 > ratios > FCF
-845045
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.2995735810753812
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-04-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
17301
Annuals > 1 > income Statement > gross Profit
-17301
Annuals > 1 > income Statement > operating Expenses
842334
Annuals > 1 > income Statement > operating Income
-842334
Annuals > 1 > income Statement > interest Expense
149842
Annuals > 1 > income Statement > pretax Income
-256658
Annuals > 1 > income Statement > net Income
-256658
Annuals > 1 > income Statement > eps
-0.0017531863878094494
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
146395159
Annuals > 1 > income Statement > income Tax Expense
41034
Annuals > 1 > income Statement > EBITDA
-842334
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
585676
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
336
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
197381
Annuals > 1 > balance Sheet > inventories
-197.38
Annuals > 1 > balance Sheet > total Current Assets
197717
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
210672
Annuals > 1 > balance Sheet > payables
1682698
Annuals > 1 > balance Sheet > short Term Debt
970300
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2936498
Annuals > 1 > balance Sheet > equity
-2725826
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-256658
Annuals > 1 > cash Flow > depreciation
17301
Annuals > 1 > cash Flow > change In Working Capital
752534
Annuals > 1 > cash Flow > cash From Operations
-41397
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
135185
Annuals > 1 > cash Flow > cash From Financing
163249
Annuals > 1 > cash Flow > net Change In Cash
336
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.0017531863878094494
Annuals > 1 > ratios > PB
-0.09130141480050451
Annuals > 1 > ratios > ROE
9.415788095058158
Annuals > 1 > ratios > ROA
-121.82824485456065
Annuals > 1 > ratios > FCF
-41397
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-04-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
65293
Annuals > 2 > income Statement > gross Profit
-65293
Annuals > 2 > income Statement > operating Expenses
2325570
Annuals > 2 > income Statement > operating Income
-2325570
Annuals > 2 > income Statement > interest Expense
75716
Annuals > 2 > income Statement > pretax Income
-3818390
Annuals > 2 > income Statement > net Income
-3818390
Annuals > 2 > income Statement > eps
-0.02729560214471195
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
139890301
Annuals > 2 > income Statement > income Tax Expense
75716
Annuals > 2 > income Statement > EBITDA
-2325570
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1492820
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
336
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
142489
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
150144
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
150144
Annuals > 2 > balance Sheet > payables
1442348
Annuals > 2 > balance Sheet > short Term Debt
676865
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2556753
Annuals > 2 > balance Sheet > equity
-2406609
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3818390
Annuals > 2 > cash Flow > depreciation
65293
Annuals > 2 > cash Flow > change In Working Capital
1336556
Annuals > 2 > cash Flow > cash From Operations
-1346890
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
135185
Annuals > 2 > cash Flow > cash From Financing
1197320
Annuals > 2 > cash Flow > net Change In Cash
-239829
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.02729560214471195
Annuals > 2 > ratios > PB
-0.09881684631778571
Annuals > 2 > ratios > ROE
158.6626660167896
Annuals > 2 > ratios > ROA
-2543.1519075021315
Annuals > 2 > ratios > FCF
-1346890
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-04-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
128130
Annuals > 3 > income Statement > gross Profit
-128130
Annuals > 3 > income Statement > operating Expenses
2472598
Annuals > 3 > income Statement > operating Income
-2474098
Annuals > 3 > income Statement > interest Expense
186065
Annuals > 3 > income Statement > pretax Income
-8265148
Annuals > 3 > income Statement > net Income
-8265148
Annuals > 3 > income Statement > eps
-0.08802347710769214
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
93897086
Annuals > 3 > income Statement > income Tax Expense
186065
Annuals > 3 > income Statement > EBITDA
-2474098
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-5791050
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
239829
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
142489
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
474692
Annuals > 3 > balance Sheet > property Plant Equipment
563811
Annuals > 3 > balance Sheet > total Assets
1603503
Annuals > 3 > balance Sheet > payables
576399
Annuals > 3 > balance Sheet > short Term Debt
566531
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1206039
Annuals > 3 > balance Sheet > equity
397464
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8265148
Annuals > 3 > cash Flow > depreciation
128130
Annuals > 3 > cash Flow > change In Working Capital
227165
Annuals > 3 > cash Flow > cash From Operations
-2133479
Annuals > 3 > cash Flow > capital Expenditures
1444842
Annuals > 3 > cash Flow > cash From Investing
-1380025
Annuals > 3 > cash Flow > cash From Financing
3002225
Annuals > 3 > cash Flow > net Change In Cash
-372959
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.08802347710769214
Annuals > 3 > ratios > PB
0.40160881538956983
Annuals > 3 > ratios > ROE
-2079.4708451583037
Annuals > 3 > ratios > ROA
-515.4432514313974
Annuals > 3 > ratios > FCF
-3578321
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
15
Valuation > metrics > PE
-0.0005882820678551576
Valuation > metrics > PB
-0.18087107871147345
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
6.259012482328151
Profitability > metrics > ROA
-26.10595771117633
Profitability > metrics > Net Margin
-0.5366459627329192
Profitability > final Score
13
Profitability > verdict
Weak
Risk > metrics > Debt Equity
-
Risk > metrics > Interest Coverage
-1.4891501240694789
Risk > final Score
24
Risk > verdict
High
Liquidity > metrics > Current Ratio
-
Liquidity > metrics > Quick Ratio
-
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
28
Prev Profitabilities > 1
18
Prev Profitabilities > 2
40
Prev Risks > 0
-2
Prev Risks > 1
10
Prev Risks > 2
-9
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-22T08:02:08.790Z
Earnings History > 0 > period
2025-01-31
Earnings History > 0 > report Date
2025-04-01
Earnings History > 0 > date
2025-01-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0004
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-10-31
Earnings History > 1 > report Date
2024-10-31
Earnings History > 1 > date
2024-10-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0009
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-07-31
Earnings History > 2 > report Date
2024-07-31
Earnings History > 2 > date
2024-07-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0006
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-04-30
Earnings History > 3 > report Date
2024-04-30
Earnings History > 3 > date
2024-04-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0097
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-01-31
Earnings History > 4 > report Date
2024-01-31
Earnings History > 4 > date
2024-01-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0009
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-10-31
Earnings History > 5 > report Date
2023-10-31
Earnings History > 5 > date
2023-10-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0007
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-07-31
Earnings History > 6 > report Date
2023-07-31
Earnings History > 6 > date
2023-07-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0017
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-04-30
Earnings History > 7 > report Date
2023-04-30
Earnings History > 7 > date
2023-04-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0036
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-01-31
Earnings History > 8 > report Date
2023-01-31
Earnings History > 8 > date
2023-01-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0011
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-10-31
Earnings History > 9 > report Date
2022-10-31
Earnings History > 9 > date
2022-10-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0006
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-07-31
Earnings History > 10 > report Date
2022-07-31
Earnings History > 10 > date
2022-07-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.0035
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-04-30
Earnings History > 11 > report Date
2022-04-30
Earnings History > 11 > date
2022-04-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.009
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-01-31
Earnings History > 12 > report Date
2022-01-31
Earnings History > 12 > date
2022-01-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0036
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-10-31
Earnings History > 13 > report Date
2021-10-31
Earnings History > 13 > date
2021-10-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0045
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-07-31
Earnings History > 14 > report Date
2021-09-30
Earnings History > 14 > date
2021-07-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0045
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-04-30
Earnings History > 15 > report Date
2021-04-30
Earnings History > 15 > date
2021-04-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0335
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-01-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Aion Therapeutic Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-01-31
EPS Actual
-0.0004
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-01-31)
(Last Updated 2025-01-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-01-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-01-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.